Prof Martin Zeier, MD, MSc, FRCP is an expert in Nephrology at University Hospital Heidelberg (Germany). As of October 2026, ScienceLeadR ranks Martin Zeier in the top 1% of experts worldwide for Kidney Transplantation. Martin Zeier has authored 691 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 2 of them ongoing. SLR score: 1,860 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Martin Zeier, MD, MSc, FRCP University Hospital Heidelberg Germany
1 860 ScienceLeadR Reputation 1860
Network Map

Nephrology

Subspecialties: Transplantation - Immunology - Urology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1987 - 2026

Source: PubMed

Heidelberg University (Germany)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 691

Citations

Citations: 22 366 1st author: 46 Last author: 111 Unique author: 9


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Diffusion tensor MR neurography reveals altered sciatic and tibial nerve microstructure in chronic dialysis patients.
PMID 42899103 — diabetes mellitus, peripheral nerves, magnetic resonance imaging, biomarkers, polyneuropathies, tibial nerve, sciatic neuropathy
Clin Kidney J20260
Short-term mycophenolic acid withdrawal is associated with temporal changes in immune cell composition in mRNA-1273-vaccinated kidney transplant recipients: insights from high-dimensional immune profiling.
PMID 42676352 — cells, monocytes, vaccines, rna, messenger, kidney, vaccination, immune system diseases, transplants, kidney transplantation, immunosuppression therapy, b-lymphocytes, transplantation, mycophenolic acid
Front Immunol20260
Proenkephalin A for assessing kidney integrity and guiding KRT liberation decisions in critically ill patients.
PMID 42571343 — kidney, critical illness, therapeutics
Ann Intensive Care20260
Renal transplantation in older recipients - results of the DZIF transplant cohort.
PMID 42410372 — incidence, aged, mycoses, sex, transplants, kidney transplantation, geriatrics, transplantation, infections
BMC Geriatr20260
Association of IgG N-Glycans With Adverse Outcomes in CKD.
PMID 42394719 — kidney diseases, mortality, polysaccharides, kidney
Kidney Int Rep20260

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 5
N/A 4
Phase 4 2
Phase 1 1
Phase 2 1

By status:

Completed 8
Unknown 3
Recruiting 2

By type:

Interventional 12
Observational 1

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 1
multicentric5to9 1
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 21

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
STOP PKD SGLT2 inhibition to Improve Prognosis in Polycystic Kidney Disease
NCT07280585 — kidney diseases, kidney, therapeutics, polycystic kidney diseases, prognosis, polycystic kidney, autosomal dominant
Phase 3Recruiting2025
Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
NCT05365672 — cells, mitomycin, safety, blood, multiple chronic conditions, kidney, body weight, transplants, therapeutics, kidney transplantation, immunosuppression therapy, infusions, intravenous, transplantation
Phase 2Recruiting2022

LeadR Networks

Main global connection map